JG
RMD icon

Jefferies Group’s ResMed RMD Stock Holding History

Jefferies Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,200
Closed -$913K – 1926
2020
Q1 		$913K Buy
+6,200
New +$988K 0.01% 1056

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Jefferies Group's RMD Position: Q3 2022 in Review

Jefferies Group opened a new position in ResMed (RMD) in Q3 2022: 14,785 shares worth $3.23M. The stake represents 0.03% of the portfolio and ranks #459 among its holdings. This is a return to the name: Jefferies Group previously reported a position in RMD as recently as Q4 2020.

Jefferies Group first reported a position in RMD in Q2 2013 and has held it in 22 quarters since. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • Jefferies Group held 14,785 shares of ResMed worth $3.23M as of Q3 2022.
  • ResMed was a new Jefferies Group position in Q3 2022.
  • ResMed made up 0.03% of Jefferies Group's portfolio in Q3 2022, its #459 holding.
  • Jefferies Group first reported a position in ResMed in Q2 2013 and has held it in 22 quarters since.
  • 667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.